Improved use of botulinum neurotoxin in the treatment of salivary gland inflammation

摘要

The present invention relates to the improved use of botulinum neurotoxin in the treatment of diseases or conditions associated with salivary gland inflammation or hypersalivation. In particular, a botulinum neurotoxin is disclosed which is administered to the parotid and submandibular glands in a dose ratio of between 1.45: 1 and 1.7: 1. [Selection diagram] None